A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP

This study aimed to compare the efficacy and safety of rituximab (RTX) plus recombinant human thrombopoietin (rhTPO) with RTX alone in patients with immune thrombocytopenia (ITP) who had failed to respond to corticosteroids or relapsed. Recruited patients were randomized at a ratio of 2:1 into 2 gro...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Blood
Hoofdauteurs: Zhou, Hai, Xu, Miao, Qin, Ping, Zhang, Hai-yan, Yuan, Cheng-lu, Zhao, Hong-guo, Cui, Zhong-guang, Meng, Yue-sheng, Wang, Lei, Zhou, Fang, Wang, Xin, Li, Da-qi, Bi, Ke-hong, Zhu, Chuan-sheng, Guo, Cheng-shan, Chu, Xiao-xia, Wu, Qing-chao, Liu, Xin-guang, Dong, Xiao-yuan, Li, Jie, Peng, Jun, Hou, Ming
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Hematology 2015
Onderwerpen:
Clinical Trials and Observations
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351949/
https://ncbi.nlm.nih.gov/pubmed/25575541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-581868
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items